K211685

Substantially Equivalent

Elecsys Testosterone II

Applicant: Roche Diagnostics
Product code: CDZ
Advisory panel: Clinical Chemistry
Date received: 2021-06-02
Decision date: 2022-05-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.